Chief Financial Officer · KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Vaseem Mahboob

FY2026 is the first fiscal year CompBrief holds for Vaseem Mahboob as a named executive officer of KESTRA MEDICAL TECHNOLOGIES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2026

$2,267,344

Compensation figures as of the proxy filed July 28, 2026 (DEF 14A).

Vaseem Mahboob compensation by year

KESTRA MEDICAL TECHNOLOGIES Summary Compensation Table · the one fiscal year held
In US dollars, as KESTRA MEDICAL TECHNOLOGIES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2026
Salary$470,000
Bonus$0
Stock awards$1,430,747
Option awards$0
Non-equity incentive$338,400
Pension and deferred compensation$0
All other$28,197
Total$2,267,344

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KESTRA MEDICAL TECHNOLOGIES, LTD. DEF 14A filed July 28, 2026, accession 0001193125-26-320956, and prior-year filings. Open the filing on EDGAR.

KESTRA MEDICAL TECHNOLOGIES’s named executive officers, FY2026

as the company reported each
Named executive officerRoleFY2026 total
Brian WebsterPresident, Chief Executive Officer & Director$7,501,904
Traci UmbergerGeneral Counsel, Chief Administrative Officer & Director$2,861,418
Al FordChief Commercial Officer$2,792,086
Vaseem Mahboob · this pageChief Financial Officer$2,267,344

The full KESTRA MEDICAL TECHNOLOGIES compensation record

free company brief

This page is one person within KESTRA MEDICAL TECHNOLOGIES's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order KESTRA MEDICAL TECHNOLOGIES's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are KESTRA MEDICAL TECHNOLOGIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy